Stock PEAR.Q PEAR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Pear Therapeutics, Inc.

Equities

PEAR.Q

US7047231052

Market Closed - OTC Markets
Other stock markets
 10:03:36 2024-03-22 am EDT 		5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for Pear Therapeutics, Inc. -.--% -.--%
Mar. 22 Disclosure Statement and Plan Approved on Interim Basis for Pear Therapeutics, Inc. CI
Mar. 04 Combined Liquidation Plan and Disclosure Statement Filed by Pear Therapeutics, Inc. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Disclosure Statement and Plan Approved on Interim Basis for Pear Therapeutics, Inc.
Third Motion for Exclusivity Period Extension Approved For Pear Therapeutics, Inc.
Second Motion for Exclusivity Period Extension Approved For Pear Therapeutics, Inc.
First Motion for Exclusivity Period Extension Approved For Pear Therapeutics, Inc.
First Motion for Exclusivity Period Extension Filed by Pear Therapeutics, Inc.
Wall Street Set to Open Lower, March Retail Sales Fall More Than Expected
US Equity Futures Mixed Ahead of Retail Sales, Industrial Production, Consumer Sentiment Reports
Top Premarket Decliners
Motion for Joint Administration Approved for Pear Therapeutics, Inc.
Top Midday Decliners
Pear Therapeutics Intends to Pursue a Sale of the Business or Assets
Pear Therapeutics, Inc. Announces Executive Changes
Pear Therapeutics, Inc. Announces Resignation of Corey Mccann, M.D., Ph.D. as Chief Executive Officer
Motion for Joint Administration Filed by Pear Therapeutics, Inc.
Pear Therapeutics, Inc. Filed for Bankruptcy
Pear Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Pear Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
Pear Therapeutics Announces Process Exploring Strategic Alternatives
Pear Therapeutics to Assess Strategic Alternatives Including Sale -- Shares Fall
Pear Therapeutics, Inc. Announces Resignation of Julia Strandberg as Chief Commercial Officer, Effective March 31, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PEAR.Q Stock
  4. News Pear Therapeutics, Inc.
  5. Other languages